On the other hand, HIF activation via the prolyl hydroxylase inhibitor Roxadustat reduced angiotensin-converting enzyme 2 (ACE2) expression and inhibited SARS-CoV-2 entry and replication, both in lung epithelial cells [45] as well as in a hamster model of infection [46]. This evidence concerns the gene ACE2 and infection.